About Calliditas Therapeutics AB (adapted from Calliditas Therapeutics AB prospectus):
They are a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Their common shares are traded on Nasdaq Stockholm under the symbol “CALTX.”

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.